
Indiana Communities Struggle to Spend Opioid Settlement Funds Amid Lack of State Oversight
When Alisha Ladyga was sixteen, she tried OxyContin for the first time in her hometown of Huntington, Indiana. It was the early 2000s, years before the opioid crisis would sweep across the nation with devastating force. By the time the epidemic reached its peak in her community, nearly everyone she knew was using drugs.
"People were overdosing left and right," Ladyga recalled. "Most of the people that I had grew up with have either passed away from opiates during that time, from overdose, or they're in prison."
Ladyga, now thirty-nine and in recovery for eleven years, represents both the human cost of Indiana's opioid crisis and the hope that sustained investment in treatment and prevention can bring. Since 1999, more than 15,000 Hoosiers have died from opioid-related causes. At the crisis peak in 2012, the state recorded nearly 112 opioid prescriptions per 100 people.
Now, Indiana communities are receiving approximately $1 billion over eighteen years from national settlements with opioid manufacturers, distributors, and pharmacies. But a joint investigation by the Arnolt Center for Investigative Journalism, the Indiana Capital Chronicle, and WTHR reveals a troubling pattern: with minimal state oversight and inadequate guidance, many municipalities are struggling to deploy these historic resources effectively. Some are spending restricted settlement funds on expenses bearing little connection to addiction treatment or prevention.
Misdirected Dollars
The investigation documented over $300,000 in settlement fund expenditures that appear to run counter to state guidelines and national settlement requirements. These funds—intended for treatment, prevention, education, and harm reduction related to substance use disorder—have instead paid for:
- Pike County: $61,114 for body cameras and law enforcement equipment
- Hancock County: $45,250 for vape sensor installation in schools
- Yorktown: More than $20,000 for police car radios
- Hobart: $14,966 for seven AEDs and electrode pairs
- Alexandria: $1,260 for box meals during the 2024 solar eclipse and $12,025 for rifle suppressors
- Delphi: $778 for parking ticket books and tow-away signs
These purchases highlight a fundamental challenge facing communities nationwide as billions in opioid settlement dollars flow to state and local governments. Without robust oversight mechanisms and clear guidance, municipalities may lack the capacity—or the will—to direct funds toward evidence-based addiction interventions.
The Oversight Gap
Indiana's approach to settlement fund oversight reflects a broader pattern of decentralized administration that places significant discretion in local hands. While the state has issued guidelines emphasizing treatment, prevention, education, and care for substance use disorders, there are no meaningful consequences for communities that deviate from these recommendations.
"I think every community has to decide for themselves the best way to spend funds," said Doug Huntsinger, executive director of the Indiana Criminal Justice Institute. "Our community providers are at the table to understand what resources are in their community, what gaps they have between resources, and how these dollars can then be used to fill those funding gaps."
Yet the investigation found that many communities were either unaware of the spending guidelines or received them too late to inform their initial allocations. The absence of state-level accountability mechanisms means that restricted abatement funds—legally obligated to address the opioid crisis—can be diverted to general municipal expenses with impunity.
This oversight vacuum stands in contrast to states that have established more structured frameworks for settlement fund deployment. Some jurisdictions have created dedicated opioid abatement authorities with independent oversight, while others have mandated public reporting and community input processes. Indiana's hands-off approach, by comparison, risks squandering a historic opportunity to address the root causes of the state's addiction crisis.
The Human Cost
For individuals like Ladyga, who began her recovery journey after receiving a twenty-five-year prison sentence with eighteen years to serve, the stakes of effective settlement fund deployment could not be higher. During her incarceration, she witnessed firsthand the revolving door of addiction and imprisonment that inadequate treatment infrastructure perpetuates.
Today, Ladyga serves on a county group considering effective uses of national opioid settlement funds. Her lived experience informs a perspective that prioritizes treatment access, recovery support, and harm reduction over punitive approaches. But without clear guidance and accountability, even well-intentioned local decision-makers may struggle to identify the interventions most likely to produce measurable outcomes.
The investigation's findings arrive as Indiana has made meaningful progress in expanding treatment capacity. The state has tripled its available residential treatment beds since 2017, reaching more than 2,900 beds statewide. This infrastructure growth represents a foundation upon which settlement funds could build—if deployed strategically.
National Context
Indiana's challenges are not unique. Across the country, states and localities are grappling with how to convert legal settlements into public health outcomes. The $50 billion-plus national opioid settlement represents the largest transfer of resources from pharmaceutical companies to communities harmed by the crisis. Yet the effectiveness of these funds depends entirely on how they are spent.
Research consistently demonstrates that certain interventions yield the strongest returns on investment: medication-assisted treatment for opioid use disorder, naloxone distribution programs, recovery housing, and peer support services. By contrast, law enforcement expenditures—while politically popular—have limited evidence of reducing overdose mortality or addressing the underlying drivers of addiction.
The tension between these approaches reflects deeper disagreements about whether the opioid crisis should be understood primarily as a criminal justice problem or a public health emergency. Settlement fund allocation decisions often reveal which framework dominates local thinking.
Pathways Forward
The Indiana investigation offers several lessons for communities nationwide seeking to maximize the impact of opioid settlement funds. First, state-level oversight mechanisms matter. Without accountability structures that can identify and correct misallocated resources, restricted funds inevitably drift toward general budget priorities.
Second, technical assistance and capacity building are essential. Many smaller communities lack the expertise to evaluate evidence-based interventions or navigate complex procurement processes for addiction services. State agencies and nonprofit partners can play a critical role in bridging this capacity gap.
Third, community engagement ensures that settlement fund deployment reflects local needs and priorities. Individuals with lived experience of addiction, recovery advocates, and family members can provide perspectives that complement administrative expertise and guard against the inertia of business-as-usual spending.
For Ladyga and the thousands of Hoosiers in recovery, the $1 billion flowing to Indiana communities represents more than a financial windfall. It is a test of whether the state can convert the pharmaceutical industry's accountability into meaningful change for people still struggling with substance use disorders. The investigation's findings suggest that without reform, much of that opportunity may be lost to body cameras, vape sensors, and parking ticket books.
As the next tranches of settlement funds arrive in coming years, Indiana faces a choice: continue the decentralized, oversight-light approach that has produced questionable expenditures, or build the infrastructure necessary to ensure these historic resources reach the treatment programs, recovery services, and prevention initiatives that can save lives.
Sources
Editorial Board
Editorial review using SAMHSA, CDC, CMS, and state agency sources
The NWVCIL editorial team reviews and updates treatment-center information using public data from SAMHSA, CDC, CMS, and state behavioral-health agencies. We cross-check facility records, state coverage rules, and clinical-practice updates so the directory reflects current evidence and policy.
Related Articles

Nevada to Receive $58 Million From Purdue-Sackler Opioid Settlement as Historic Deal Takes Effect
Nevada expects $57.9 million over 15 years from the $7.4 billion Purdue Pharma and Sackler family settlement, bringing the state's total opioid settlement recovery to over $1.2 billion.

Wisconsin to Receive Over $80 Million From Purdue Pharma Opioid Settlement
Wisconsin will receive more than $80 million from the $7.4 billion Purdue Pharma and Sackler family settlement, with 70% directed to county and local governments for addiction treatment and prevention programs.

Oregon Allocates $90 Million in Opioid Settlement Funds to Expand Prevention, Treatment, and Recovery Services
Oregon Health Authority announces $90 million in opioid settlement funding distributed over two years to support prevention, treatment, and recovery services as overdose deaths decline for the second consecutive year.